(KPTI) Karyopharm Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Karyopharm Therapeutics | (KPTI) share price targets
Complete technical analysis of Karyopharm Therapeutics (KPTI) by charts plus indicators, forecast predictions and share price targets for Karyopharm Therapeutics (KPTI)
Karyopharm Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-07-11 View latest technical analysis
10 day averaged volume of Karyopharm Therapeutics is 2477820
Date | Daily Closing Price | Open | High | Low | Volume |
11 Thu Jul 2024 | 0.96 | 0.90 | 0.97 | 0.87 | 0.24 times |
10 Wed Jul 2024 | 0.87 | 0.84 | 0.90 | 0.83 | 0.175 times |
09 Tue Jul 2024 | 0.84 | 0.79 | 0.86 | 0.77 | 0.6 times |
08 Mon Jul 2024 | 0.79 | 0.83 | 0.85 | 0.79 | 0.54 times |
05 Fri Jul 2024 | 0.82 | 0.85 | 0.85 | 0.79 | 0.357 times |
03 Wed Jul 2024 | 0.83 | 0.83 | 0.87 | 0.81 | 0.218 times |
03 Wed Jul 2024 | 0.83 | 0.83 | 0.87 | 0.81 | 0.218 times |
02 Tue Jul 2024 | 0.80 | 0.82 | 0.84 | 0.79 | 0.842 times |
01 Mon Jul 2024 | 0.82 | 0.89 | 0.91 | 0.82 | 0.726 times |
28 Fri Jun 2024 | 0.87 | 0.95 | 1.02 | 0.87 | 5.768 times |
My analysis of stock is bullish for shortterm, and stock might move up till 1 or till 1.1. Use a stoploss of 0.92 and if this stock hits its stoploss, then it can fall down till 0.83
Share price targets for Karyopharm Therapeutics (KPTI)
Target Type | Value |
Downside Target | 0.77 |
Downside Target | 0.79 |
Downside Target | 0.87 |
Downside Target | 0.90 |
Upside Target | 0.97 |
Upside Target | 1.00 |
Upside Target | 1.02 |
Upside Target | 1.13 |
Upside Target | 1.16 |
Upside Target | 1.20 |
Upside Target | 1.65 |
Upside Target | 1.70 |
Intraday share price targets for Karyopharm Therapeutics (KPTI)
Target Type | Value |
Downside Intraday Target | 0.83 |
Downside Intraday Target | 0.7 |
Upside Intraday Target | 1.03 |
Upside Intraday Target | 1.1 |
Downside Intraday Target | 0.9 |
Weekly technical analysis of Karyopharm Therapeutics (KPTI)
Date | Weekly Closing Price | Open | High | Low | Volume |
11 Thu Jul 2024 | 0.96 | 0.83 | 0.97 | 0.77 | 2.704 times |
05 Fri Jul 2024 | 0.82 | 0.83 | 0.87 | 0.79 | 0.322 times |
03 Wed Jul 2024 | 0.83 | 0.89 | 0.91 | 0.79 | 0.221 times |
28 Fri Jun 2024 | 0.87 | 0.97 | 1.16 | 0.87 | 8.313 times |
21 Fri Jun 2024 | 0.98 | 0.97 | 1.00 | 0.90 | 2.239 times |
Price has moved up this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Karyopharm Therapeutics (KPTI)
Date | Monthly Closing Price | Open | High | Low | Volume |
11 Thu Jul 2024 | 0.96 | 0.89 | 0.97 | 0.77 | 0.269 times |
28 Fri Jun 2024 | 0.87 | 0.98 | 1.16 | 0.87 | 1.261 times |
31 Fri May 2024 | 0.97 | 1.06 | 1.20 | 0.91 | 1.122 times |
30 Tue Apr 2024 | 1.03 | 1.51 | 1.65 | 1.02 | 1.039 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Karyopharm Therapeutics (KPTI)
Price action analysis of Karyopharm Therapeutics ( (KPTI) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Karyopharm Therapeutics ( (KPTI) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Karyopharm Therapeutics ( (KPTI) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Karyopharm Therapeutics ( (KPTI) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Karyopharm Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Karyopharm Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Karyopharm Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Karyopharm Therapeutics in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Karyopharm Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.85 and Karyopharm Therapeutics (KPTI) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Karyopharm Therapeutics (KPTI) stock. Volume based technical analysis of Karyopharm Therapeutics (KPTI) stock is negative.
Karyopharm Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Karyopharm Therapeutics ( (KPTI) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Karyopharm Therapeutics ( (KPTI) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Karyopharm Therapeutics ( (KPTI) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Karyopharm Therapeutics ( (KPTI) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Karyopharm Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Karyopharm Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Karyopharm Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Karyopharm Therapeutics in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Karyopharm Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.85 and Karyopharm Therapeutics (KPTI) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Karyopharm Therapeutics (KPTI) stock. Volume based technical analysis of Karyopharm Therapeutics (KPTI) stock is negative.
Karyopharm Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.